SFS
ITRM

Sowell Financial Services’s Iterum Therapeutics ITRM Stock Holding History

Sowell Financial Services’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-207
Closed -$3K – 1613
2021
Q1 		$3K Buy
+207
New +$4.93K ﹤0.01% 2739

Other funds holding ITRM

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Sowell Financial Services's ITRM Position: Q2 2021 in Review

Sowell Financial Services sold out of Iterum Therapeutics (ITRM) in Q2 2021, closing a stake of 207 shares — an estimated $3K sold.

Sowell Financial Services first reported a position in ITRM in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 44 funds tracked by Wall St. Rank hold ITRM as of Q2 2021.

  • Sowell Financial Services reported no remaining Iterum Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 207 Iterum Therapeutics shares in Q2 2021, an estimated $3K.
  • Sowell Financial Services first reported a position in Iterum Therapeutics in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Iterum Therapeutics position peaked at $3K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.